Jacek Jassem
Expertise in
10
conditions

Jacek Jassem

17 Smoluchowskiego St, 
Gdansk, PM, PL 
Expertise in
10
conditions
17 Smoluchowskiego St, 
Gdansk, PM, PL 

Overview

Jacek Jassem practices practicing medicine in Gdansk, Poland.

Mr. Jassem is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Mastectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 357 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

17 Smoluchowskiego St, Gdansk, PM 80214, Poland
Other Locations
14 Smoluchowskiego St, Gdansk, PM 80214, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II, Open Label, Single Arm Study to Investigate Anti-tumor Effect of Ixabepilone in Patients With Locally Recurrent or Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP After Failure of an Anthracycline and Taxanes.
Phase II, Open Label, Single Arm Study to Investigate Anti-tumor Effect of Ixabepilone in Patients With Locally Recurrent or Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP After Failure of an Anthracycline and Taxanes.
Enrollment Status: Terminated
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: Ixabepilone Injection
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

357 Total Publications

Mutational landscapes of brain metastases across various histological subtypes of lung cancer.
Mutational landscapes of brain metastases across various histological subtypes of lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 27, 2025

Frequently Asked Questions about Jacek Jassem

Is Jacek Jassem a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jacek Jassem is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jacek Jassem participate in research or clinical trials?

Yes. Jacek Jassem has published 357 articles and abstracts on conditions like Lung Cancer. You can view a list of Jacek Jassem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jassem's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile